634913-39-6 Usage
Uses
Used in Pharmaceutical Synthesis:
2-[3,5-bis(trifluoromethyl)phenyl]carbamoyl-4-chlorophenyl dihydrogen phosphate is utilized as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drug molecules with potential therapeutic effects.
Used in Agrochemical Production:
In the agrochemical industry, 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate serves as a key component in the creation of pesticides and other crop protection agents, leveraging its chemical properties to enhance the effectiveness of these products.
Used in Materials Science:
2-[3,5-bis(trifluoromethyl)phenyl]carbamoyl-4-chlorophenyl dihydrogen phosphate is applied in materials science for its potential to improve or create new materials with specific characteristics, such as high thermal stability or chemical resistance.
Used as a Flame Retardant:
Due to the presence of the phosphate group, 2-[3,5-bis(trifluoromethyl)phenyl]carbamoyl-4-chlorophenyl dihydrogen phosphate has potential use as a flame retardant, providing a chemical means to enhance the fire safety of various materials.
The diverse applications of 2-[3,5-bis(trifluoromethyl)phenyl]carbamoyl-4-chlorophenyl dihydrogen phosphate underscore its importance in chemical research and industrial development, warranting further investigation into its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 634913-39-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,4,9,1 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 634913-39:
(8*6)+(7*3)+(6*4)+(5*9)+(4*1)+(3*3)+(2*3)+(1*9)=166
166 % 10 = 6
So 634913-39-6 is a valid CAS Registry Number.
634913-39-6Relevant articles and documents
O-SUBSTITUTED HYDROXYARYL DERIVATIVES
-
, (2008/06/13)
A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in a main chain is 2 to 5 (said connecting group may be substituted), "A" represents an acyl group which may be substituted, (provided that unsubstituted acetyl group and unsubstituted acryloyl group are excluded,) or a C1 to C6 alkyl group which may be substituted, or A may bind to connecting group X to form a cyclic structure which may be substituted, "E" represents an aryl group which may be substituted or a heteroaryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.
